Search Results 411-420 of 17661 for Prednisone

1. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or ...

2. Lutetium lu 177 dotatate (intravenous route) - Mayo Clinic

   Prednisone. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

3. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

   Receiving chronic systemic corticosteroid therapy > 20 mg of prednisone daily. Being treated with other anti-cancer therapies (approved or investigational) ...

4. A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis - Mayo Clinic

   Corticosteroids >10 mg/day prednisone or equivalent; Erythropoietin. Incomplete recovery from major surgery within four weeks of study entry; Radiation therapy ...

5. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   insufficiency are eligible if on a stable dose of prednisone =< 10 mg or equivalent - ELIGIBILITY CRITERIA (STEP 1): Patients must not have an uncontrolled ...

6. A Study to Assess the Feasibility of Folate Scan in Patients with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   Immunosuppressive therapy (> 5 mg/day of Prednisone or inhaled corticosteroids); Pregnancy or breast feeding; Subject is mentally incapable of understanding ...

7. Triamcinolone (injection route) - Mayo Clinic

   Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

8. Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome - Mayo Clinic

   * Subjects with a condition requiring systemic treatment with either corticosteroids (\> 10 mg daily prednisone equivalents) or other immunosuppressive ...

9. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

   Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2. For patients receiving corticosteroids, the dose must be ≤ 10 mg/day of prednisone or ...

10. Leflunomide (oral route) - Mayo Clinic

    Leflunomide is used to treat active rheumatoid arthritis. This medicine works by stopping the body from producing too many of the immune cells that are ...